Zarontin · DIN 00022799 · 250 mg · capsule
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Zarontin · DIN 00022799
Manufacturer: Searchlight Pharma Inc.; listing date 1996-10-01
Health Canada: Marketed since 2022-10-11 · brand ZARONTIN · ATC N03AD01 ETHOSUXIMIDE · form Capsule · route Oral · ingredients ETHOSUXIMIDE 250 MG · company Searchlight pharma inc · schedule Prescription
Ministry pays: $0.2628 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00022799)
Source record
DIN 00022799: Zarontin
Raw flags: sec3=Y
Item: 281200008; group id 429; item number 1068; lccId None; manufacturer id SLP
Source form: Cap; strength: 250mg
Recorded listing: General benefit
Source prices (unrounded): $0.5255; ministry $0.2628
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00022799
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=771
Interchangeable products
Mar-Ethosuximide · DIN 02545772 · $0.2628
Odan-Ethosuximide · DIN 02547171 · $0.2628
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00022799
Shortage record checked October 6, 2026